Azenta, Inc. (AZTA)
After hours:
| Previous Close | 50.87 |
| Open | 50.98 |
| Bid | 51.43 x 100 |
| Ask | 51.54 x 200 |
| Day's Range | 50.71 - 51.52 |
| 52 Week Range | 41.20 - 69.16 |
| Volume | |
| Avg. Volume | 480,056 |
| Market Cap | 2.776B |
| Beta (5Y Monthly) | 1.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 02, 2021 |
| 1y Target Est | N/A |
- PR Newswire
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market. The new laboratory brings Azenta closer to UK-based researchers, providing advanced next-generation sequencing (NGS) platforms and a local team of top-tier scientists from Oxford.
- PR Newswire
Azenta Announces CEO Succession Plan
Azenta, Inc. (Nasdaq: AZTA) today announced a CEO succession plan, under which CEO and Board Director Dr. Stephen Schwartz will be retiring from Azenta after more than 14 years of service. Dr. Schwartz will continue to serve as CEO until a successor is appointed to ensure a smooth transition.
- PR Newswire
Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2024.
